Synthesis and neuroleptic activity of N-[(1-ethyl-2-pyrrolidinyl) methyl]-2-methoxy-5-sulfonamidobenzamides

M Ogata, H Matsumoto, S Kida, T Shiomi…

Index: Journal of Medicinal Chemistry, , vol. 27, # 9 p. 1137 - 1141

Full Text: HTML

Citation Number: 3

Abstract

... SOC. 1917, 111, 220. (8) Beilstein 10, 237. (9) Goldstein, H.; Schaaf, E. Helu. Chim. Acta 1967, 40, 369. 0022-2623/84/1827-1137$01.50/0 0 1984 American Chemical Society Page 2. 1138 Journal of Medicinal Chemistry, 1984, Vol. 27, No. 9 Ogata et al. ...

Mizoroki–Heck Reactions with 4??Phenoldiazonium Salts

[Schmidt, Bernd; Hoelter, Frank; Berger, Rene; Jessel, Soenke Advanced Synthesis and Catalysis, 2010 , vol. 352, # 14-15 p. 2463 - 2473]

Design and Synthesis of Novel Cyclooxygenase??1 Inhibitors a...

[Fukai, Ryosuke; Zheng, Xiaoxia; Motoshima, Kazunori; Tai, Akihiro; Yazama, Futoshi; Kakuta, Hiroki ChemMedChem, 2011 , vol. 6, # 3 p. 550 - 560]

(S)-N-[(1-ethyl-2-pyrrolidinyl) methyl]-5-[125I] iodo-2-meth...

[Paulis, Tomas de; Janowsky, Aaron; Kessler, Robert M.; Clanton, Jeffrey A.; Smith, Howard E. Journal of Medicinal Chemistry, 1988 , vol. 31, # 10 p. 2027 - 2033]

Strategic studies in the syntheses of novel 6, 7-substituted...

[Morgentin, Remy; Pasquet, Georges; Boutron, Pascal; Jung, Frederic; Lamorlette, Maryannick; Maudet, Mickael; Ple, Patrick Tetrahedron, 2008 , vol. 64, # 12 p. 2772 - 2782]